•
Dec 31, 2020

Keurig Dr Pepper Q4 2020 Earnings Report

Keurig Dr Pepper reported a strong finish to 2020, delivering full year results at the top of its guidance range, including accelerated growth in net sales.

Key Takeaways

Keurig Dr Pepper reported a strong fourth quarter and full year ended December 31, 2020, with net sales growth of 6.4% in Q4. The company's performance was driven by market share gains and increased household adoption of the Keurig system. KDP expects to deliver another year of strong net sales growth in 2021.

Delivered strong net sales growth, driven by market share gains across the portfolio.

Successfully responded to the COVID-19 pandemic, keeping employees safe and delivering for customers.

Grew market share in more than 90% of the Company’s cold beverage retail base.

Generated exceptionally strong free cash flow, enabling debt reduction.

Total Revenue
$3.12B
Previous year: $2.93B
+6.4%
EPS
$0.39
Previous year: $0.35
+11.4%
Gross Profit
$1.77B
Previous year: $1.69B
+4.4%
Cash and Equivalents
$240M
Previous year: $75M
+220.0%
Free Cash Flow
$685M
Previous year: $549M
+24.8%
Total Assets
$49.8B
Previous year: $49.5B
+0.5%

Keurig Dr Pepper

Keurig Dr Pepper

Forward Guidance

KDP expects to deliver another year of strong net sales growth in 2021, positioning the Company to exceed its three-year merger target of 2-3% average annual growth. Adjusted diluted EPS is again expected to grow by double-digits, enabling KDP to meet its three-year merger target of 15-17% average annual growth.

Positive Outlook

  • Constant currency net sales growth is expected in the range of 3-4% in 2021, driven by investments in innovation and marketing.
  • Benefits of recent partnerships and ongoing strong in-market execution.
  • Adjusted diluted EPS growth is expected in the range of 13% to 15%.
  • Benefits of the strong top-line performance and continued merger synergies and productivity.
  • Reduced interest expense and improvement in the Company’s effective tax rate.

Challenges Ahead

  • Merger synergies of approximately $200 million.
  • Adjusted interest expense in the range of $505 million to $515 million.
  • Adjusted effective tax rate in the range of 23.5% to 24.0%.
  • Diluted weighted average shares outstanding of approximately 1,430 million.
  • Management leverage ratio at or below 3.0x at year end 2021.